Detection of p53 in inflammatory tissue and lymphocytes using immunohistology and flow cytometry: a critical comment.
Open Access
- 1 August 1997
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 50 (8) , 654-660
- https://doi.org/10.1136/jcp.50.8.654
Abstract
AIMS: To analyse the expression of p53 in lymphatic cells found in inflammatory tissues and the peripheral blood by immunological methods. METHODS: Immunohistological analysis of synovial tissues from patients with rheumatoid arthritis and flow cytometric analysis of peripheral blood lymphocytes were performed with anti-p53 antibodies from different sources. RESULTS: The anti-p53 antibodies PAb240, PAb421, and PAb1801 from one supplier bound to the cytoplasm of lymphocytes, fibroblasts, and endothelial cells in rheumatoid synovial tissue, while the same anti-p53 antibodies from other sources and the p53 specific antibodies PAb1620 and DO1 were negative. Using flow cytometry, the antibodies that labelled cells in inflammatory tissues were shown to bind also to peripheral lymphocytes, while the antibodies that were negative in immunohistology did not react with peripheral blood lymphocytes. p53 expression could be confirmed by western blot in rheumatoid synovial tissue, but not in peripheral blood lymphocytes using PAb421 and PAb240 antibodies from our own laboratory, which had been negative in immunohistology. CONCLUSIONS: Demonstration of p53 by western blot is more sensitive and reliable than immunohistology and flow cytometry. Western blot is the gold standard for the demonstration of p53 expression and should be used, whenever possible, to confirm p53 expression in normal tissue shown by immunohistology or flow cytometry. All other reports on p53 expression, especially those obtained using antibodies with an unusual staining pattern must be interpreted with caution.Keywords
This publication has 43 references indexed in Scilit:
- Mutant p53 protein as a predictor of survival in endometrial carcinomaEuropean Journal Of Cancer, 1996
- MDM2 expression in lymphoid cells and reactive and neoplastic lymphoid tissue. Comparative study with p53 expressionThe Journal of Pathology, 1995
- Increased p53 Protein Associated with Aging in Human Diploid FibroblastsExperimental Cell Research, 1995
- p53, Rb and bcl-2 expression during the cell cycle: a study in phytohaemagglutinin stimulated lymphocytes and microwave irradiated lymphoid tissue sections.Journal of Clinical Pathology, 1995
- p53: DNA damage, DNA repair, and apoptosisPublished by Springer Nature ,1995
- Antibody for detecting p53 protein by immunohistochemistry in normal tissues.Journal of Clinical Pathology, 1994
- Immunochemical analysis of the p53 oncoprotein in matched primary and metastatic human tumoursEuropean Journal Of Cancer, 1993
- Expression of p53 protein in benign and malignant epidermal pathologic conditionsJournal of the American Academy of Dermatology, 1993
- Abnormal expression of wild type p53 protein in normal cells of a cancer family patientThe Lancet, 1992
- Different forms of p53 detected by monoclonal antibodies in non-dividing and dividing lymphocytesNature, 1984